Disclosure of International Relationships & Activities – Sponsor Guidance

Dear Investigator,

I write to update you on recent sponsor guidance regarding the disclosure of international relationships and activities and of your obligations to report such activities to the University and federal sponsors.  The SPS website (see foreign collaborations) continues to be updated to include sponsor-released guidance as we become aware of it.

Please review the updates below for any sponsors to which you plan to apply or with which you are currently engaged to ensure you are aware of and compliant with their requirements.  Additionally, and as a reminder, you must seek prior approval for consulting and disclose any significant financial interests to the University.

The following topics are covered below:

Department of Defense Update

National Institutes of Health Update

National Science Foundation Update

Letter from Office of Science and Technology Policy

Recent Articles

Where do I get help?

 

Sponsor Updates

Department of Defense

Recently, the Under Secretary of Defense issued a memo dated October 10, 2019, which lays out DoD’s steps to date to “limit undue influence by countries that desire to exploit DoD research, science and technology, and innovation enterprise through foreign talent programs and other means” and steps DoD plans to pursue. The memo calls for a dynamic, Government wide, partnership, since “[no] laboratory, university, industry partner, or Government agency can address the full scope of this challenge alone, and solutions to this problem can only result from a dynamic partnership between our public and private sectors.”  This memo follows directives by the DoD in Notices of funding Opportunities related to research and research-related educational activities to include requirements to “submit additional Current and Active support information for all key personnel, whether or not the individuals are to be funded by the DoD.”

Disclose all current and pending projects, whether or not they are funded through UConn including foreign projects.

National Institutes of Health

The Council on Governmental Relations released a Guide for meeting disclosure requirements under Notice NOT OD-19-114.  The NIH requires reporting of research support from internal and external sources and the relationship to the NIH funding as critical information for NIH and grantee institutions to assess scientific budgetary overlap, and availability of time to commit to NIH funded projects.  Based on conversations COGR staff have had with the NIH, the following summarizes COGR’s understanding of what the NIH is requiring.

  1. Key personnel must disclose funding for all research activities regardless of where the research will be carried out.
  2. Key personnel must disclose start-up packages and support for research from entities other than the applicant intuition.
  3. Disclosing In Kind- Support
  • Key personnel must disclose in-kind resources that are uniquely available to key personnel (office/laboratory space, equipment, supplies, employees) including those available outside the applicant institution; details about in-kind personnel who are expected to work directly on a proposed project; report details of in-kind support in the Facilities and Other Resources section or in Other Support section of the application; report details of individuals who have expended at least one month of effort during the year (compensated or uncompensated) in the annual report (no change).
    • Key personnel are not responsible for disclosing institution-wide resources such as core facilities or shared equipment that are made broadly available.
  1. Key personnel must disclose affiliations or appointments that are likely to be cited in NIH-funded publications in the biosketch section of the application.
  2. Prior approval is required before initiating a new “foreign component” per current NIH policy (no change).

National Science Foundation

The National Science Foundation issued their draft 2020 Proposal and Award Policies and Procedures Guide (PAPPG) for comment in May 2019, which included a requirement for senior personnel to report in grant proposals all sources of funding and payments, whether paid through the applicant institution or paid directly to the individual. NSF is currently reviewing comments and has not issued any new policies yet.

Disclose all current and pending projects, whether or not they are funded through UConn including foreign projects.

Office of the President, Office of Science and Technology Policy

A letter was sent to US researchers from Director Kelvin K. Droegemeier about the Joint Committee on the Research Environment and research security.  The committee’s work in this area is organized along four lines of effort: coordinating outreach and engagement, establishing and coordinating disclosure requirements, developing best practices for academic research institutions and developing methods for identification, assessment, and management of risk.  He writes, “Working together, we will ensure that our research environments are safe and inclusive; operate with maximum integrity; protect our research assets in a manner balanced with openness and international collaboration that have been so critical to our success; and do not encumber researchers, agencies or institutions with unnecessary administrative work.”

Recent Articles

August 2019, Professor Indicted for Alleged Undisclosed Chinese Links, Inside Higher Ed article on the investigation and prosecution on a University of Kansas research professor.

September 2019, NIH Reveals Its formula for Tracking Foreign Influences, Science article on NIH methodology for threat identification.

November 2019, Vast Dragnet Targets Theft of Biomedical Secrets for China, New York Times article that covers recent federal investigations.

Where do I get help?

The University has offices to assist investigators in these areas.  Each investigator has a responsibility to make sure they are compliant with all relevant University policies and federal requirements.  These offices are here to assist and always welcome inquiries.  Please feel free to reach out for help if you have questions:

Faculty Consulting Office

Sarah Croucher: sarah.croucher@uconn.edu; 486-5630 (Storrs and Regional Campuses)

Scott Wetstone: wetstone@uchc.edu; 679-4440 (UConn Health)

Financial Conflict Interest Services – see Storrs and Regional Campuses or UConn Health

Sponsored Program Services

Laura Kozma: laura.kozma@uconn.edu; 486-3798 (Storrs and Regional Campuses)

Paul Hudobenko: hudobenko@uchc.edu; 679-3951 (UConn Health)

Export Control Services

Carol Connolly: carol.connolly@uconn.edu; 486-3994

General Questions and Guidance

Michael Glasgow: michael.glasgow@uconn.edu; 486-5011

 

Please don’t hesitate to contact any of us if you have questions or need assistance on these matters.

With regards,

Mike Glasgow
Associate Vice President for Research
Sponsored Programs Services

Export of Research Materials Abroad

To the UConn/UConn Health research community:

The Council on Government Relations (COGR) has issued an alert regarding recent situations where researchers have attempted to export research materials abroad. The FBI and other federal law enforcement agencies have increased their surveillance efforts to identify transport of research materials and verify that those exports comply with federal laws. These efforts are believed to be part of a nation-wide enforcement action to control the transport of biological materials that may present a threat to our national security and/or reduce the theft of intellectual property developed in the US, much of it with federal funds.

Transporting certain materials may require import/export permits or other documentation from federal agencies, including US Customs and Border Protection (CBP), the FDA, USDA, Fish and Wildlife, and the CDC.

Anyone with questions should contact the applicable federal agency or the UConn Export Control Office (exportcontrol@uconn.edu) for assistance.

Related news:

 

Wesley G. Byerly, Pharm.D.

Associate Vice President

Mitigating the Impact of Fringe Costs on Research at UConn

Dear Colleagues,

I write to inform you that I am taking action to help mitigate the burden our faculty face when competing for research grants due to the high fringe benefit rates being charged to UConn by the state. To address this issue, we will apply funds to reduce these rates across the board for the near-term. These reduced rates can be used in proposal submissions starting January 1, 2020. On the left, below, are the current rates. On the right are the new rates:

 

Current Rates New Rates for 7/1/20 – 6/30/21
Professional 64.8% 43%
Faculty 53.2% 43%
Graduate/Post Doc: 17.2% 15.5%
Special Payroll 24.3% 19.5%
Student 4.1% 2.4%

 

Additional details regarding proposal submissions, timelines, budgeting, and FAQs will be forthcoming from the Office of the Vice President for Research.

The overriding goal is to help create a more level playing field for UConn faculty as you compete nationally for grants by reducing our fringe costs so they are closer to those found at peer and aspirant institutions.

I am taking this action after numerous conversations with faculty since arriving at UConn in August, and in light of the evidence of the challenges our fringe costs create. We know from actual grant reviews that our fringe rates are out of line with those institutions directly competing with UConn for grant dollars. In some cases, our faculty must forgo funding opportunities simply because they cannot make the budgets work because of the higher fringe costs.

The capacity of faculty to turn hard-won grants into important research products is significantly reduced, including those associated with efforts to drive economic growth and innovation for the state of Connecticut. Furthermore, this reduced competitiveness increases the challenge of recruiting and retaining outstanding faculty.

Overall, these high rates have a significant negative impact on the University’s research mission and addressing them is a critical priority.

However, this is a temporary, stop-gap measure, not a permanent solution and it is not something we would do in the ordinary course of business. As you may know, these rates are abnormally high because of Connecticut’s substantial unfunded pension and retiree health insurance liabilities. The cost of that legacy unfunded liability is built into our fringe rates, inflating them. We are working closely with the state to identify a permanent solution to this problem, as UConn does not and will not have the resources needed to address this issue on our own over the long term. But, in my judgment, the need to reduce rates at UConn is urgent enough that we must act now and use our one-time funds prudently as we seek a lasting solution.

This will apply to the Storrs and regional campuses only. At UConn Health, we addressed this same issue some months ago for the current fiscal year. We have budgeted funds to cover a portion of the unfunded liability charged to UConn Health, providing immediate relief on existing grants. We are committed to working with the state to find a long term solution to this ongoing problem, university-wide.

It is my hope that this will make our faculty more competitive as you seek grants, allow you to apply more of your grant funds to your actual research and related costs, and make it easier for UConn to recruit and retain faculty going forward.

Once again, details from the OVPR will be provided in the coming weeks.

I wish you the best of luck on your upcoming grant applications and happy holidays!

Sincerely,

Tom
President
University of Connecticut

 

Follow me on Twitter and Instagram

NIH Asks For Your Feedback

The Office of the Vice President for Research would like to share some information regarding data sharing with researchers who may be affected.

The National Institutes of Health (NIH) is requesting comments on the draft NIH Policy for Data Management and Sharing and Supplemental Draft Guidance.

NIH will be hosting an informational webinar on the draft NIH policy and guidance on Monday, December 16th from 12:30-2:00 PM ET. The purpose of the webinar is to provide information on the draft policy and answer questions about the public comment process.

Submit your comments to NIH by January 10, 2020. Additional information can be found in this NIH blog post. Questions about the draft may be sent to the NIH Office of Science Policy at SciencePolicy@od.nih.gov.

For questions, please contact Research Compliance Monitor, Ellen Ciesielski at 860.679.6004.

OVPR Quarterly Reports – FY19Q4

Dear Colleagues,

Now that data have been finalized, I would like to provide you with the FY19 Proposals, Awards, and Expenditures report relating to sponsored program activity—both research and education/service—managed by Sponsored Program Services within the Office of the Vice President for Research at UConn and UConn Health.

In the report, data are presented in two ways: by the PI’s Academic Home Department and by the Managing Department or Center/Institute. Please refer to the first page of the report for definitions and information regarding the data. Should you have any questions regarding this report, please do not hesitate to contact me. Please visit the OVPR website to view current and archived reports: OVPR Reports.

Please note that we have included an additional Summary of Sponsored Program Activity, which includes the Effective F&A rate on awards. This information provides a snapshot of our activity as compared to the same period last year.

While fluctuations from year to year in both grant awards and proposal submissions are common, the government shut down in January further impacted the timing of some awards and proposal submissions this year, which likely contributed to the reductions in overall numbers of individual submitted proposals and awards received. New awarded amounts are up in total, with Storrs and regional campuses ending the year slightly below last year’s totals and UConn Health receiving $8.4M more than last year. Overall dollars requested in proposals increased from $1.24M in FY18 to $1.26M in FY19.

The OVPR continues to seek creative solutions that allow UConn and UConn Health to grow our research enterprise through federal funding, industry partnerships, and collaboration with foundations. I am confident we can continue upward trends by continuing to work together, aggressively applying for extramural funding, and pursuing new channels of support for the tremendous research, scholarship, and creative activities taking place every day at UConn and UConn Health.

Thank you for your continued commitment and contribution to our students, to your research and scholarship, and to UConn/UConn Health.

Sincerely,

Radenka

Dr. Radenka Maric
Vice President for Research
UConn/UConn Health

START Preliminary Proof of Concept Fund

Dear Colleagues,

 

Through a generous grant provided by the CTNext Higher Education Fund last year, the Office of the Vice President for Research (OVPR) has been administering an early stage translational research funding program called the START Preliminary Proof of Concept (PPOC) Fund. Under the grant, funding is provided to investigators at Central Connecticut State University (CCSU), Southern Connecticut State University (SCSU), University of Bridgeport (UB), and UConn on a competitive basis.

 

The START program aims to support the preliminary validation of innovative early stage technologies that have possible commercial potential and is designed to advance those technologies to be more attractive for additional funding. Proposals for the START PPOC Fund are welcomed from across all disciplines for early stage projects that may one day result in inventions and technologies that address unmet needs and have potential for commercial application.

 

As we wrap up the first year on funding, I would like to take a moment to recognize recipients from these institutions and ask that you join me in congratulating them on their efforts to commercialize technologies developed in the course of their academic research. For a full list of recipients and project information, visit the OVPR website.

 

For more information about the competition, visit the program website.

 

Thank you for helping to foster the culture of excellence in your schools/colleges, departments, and centers that allows UConn faculty to engage in research, scholarship, and creative activities at the highest levels. 

 

 

Cheers,

Radenka

Celebrating UConn Research, Scholarship, and Creative Activities

As we begin a new semester at UConn, I would like to reflect on our past academic year and share with you the excitement, successes, and progress we made in that time. As a public research university that engages globally in the creation of new knowledge, we measure our success by the impact of our scholarly and educational outcomes, research, innovation, and the creative work of our students and faculty. In the last few years, we have brought people together around shared goals across campuses and disciplines, an accomplishment that is palpable at UConn and has been critical to the success of our land-grant mission.

Our three consecutive years of growth in total awards have borne out the value of our collective efforts.

Thanks to the tireless work of our faculty, postdocs, students, and staff, our new extramural awards for FY19 reached a three-year high of $266.2M. In FY17, our total new awards were $184.5M and in FY18, they were $258M. UConn Health received over $100M in new awards this past fiscal year reaching an all-time high. Our combined efforts represent a 44% increase over three years. We also saw upward trends in our entrepreneurship and innovation ecosystem, with a record 39 high-potential startup companies joining UConn’s Technology Incubation Program, and a ranking of 93rd worldwide in the number of US patents issued for UConn inventions. It is a matter of great satisfaction for me to have helped position entrepreneurship and innovation as an equal mission for our faculty alongside teaching, scholarship, research and creative work.

Our committed focus on seed funding, proof of concept grants, and awards to support the arts and humanities has contributed to STEM and non-STEM excellence. In FY19, our office contributed $2.3M to internal funding programs and an additional $100K to support grant writing workshops and resources. We are thrilled to see engagement, collaboration, and distinction from all areas of the University, whether it be STEM, non-STEM, or a collaborative hybrid, and that these combined efforts are producing growth in research and extramural awards.

I would like to highlight a few new initiatives launched by the OVPR in FY19 that supported faculty success:

  • Convergence Awards for Research in Interdisciplinary Centers (CARIC): Support development of collaborative interdisciplinary teams to bid for major (>$5M) federally funded initiatives, such as research centers.
  • Support of UConn Human Rights Institute with two postdoctoral fellowships in collaboration with the Schools of Engineering and Business.
  • Program in Accelerated Therapeutics for Healthcare (PATH): In partnership with the Schools of Pharmacy and Medicine, aims to accelerate the translational pathway to convert discoveries into new medical therapeutics. The program seeks to quickly develop novel approaches focusing on well validated molecular targets for a specific disease area with an unmet treatment need in the current commercial marketplace.
  • Scholarship and Collaboration in Humanities and Arts Research Program (SCHARP): In partnership with the Humanities Institute, SCHARP supports innovative works in scholarship and creative activities in the arts and humanities that have the potential to transform a field of study, impact the common good, or chart a new direction in scholarly, creative, or artistic direction.
  • STEAM Innovation Grant: In partnership with the School of Fine Arts, STEAM encourages innovative collaborations between the arts and STEM disciplines. Projects funded by this grant may result in publications, exhibitions, performances, academic symposia, or other research outcomes.
  • Stamford Innovate, a new internship program that connects talented UConn students with opportunities in startups in one of the fastest growing regions of the state.

If you want to learn more, click here for a full list of our internal funding programs.

As educators, we all take great pride in our students’ successes, and I wanted to take a moment to recognize some new student projects that are truly remarkable. In collaboration with the Office of the Provost, the OVPR supported a student-led podcast called In Vivo. With regular interviews about science, the arts, current events, and other topics, In Vivo highlights the amazing faculty, students, and staff that give UConn life. The show is conducted out of UConn’s WHUS studio and is run entirely by UConn students. Check it out and consider subscribing for future episodes to learn more about UConn researchers.

Another new initiative is World Poetry Books to support its mission of publishing and vigorously promoting a minimum of six books of exceptional poetry in translation each year. This support offers our students the opportunity to gain hands-on, professional publishing skills, and establishes UConn as home of a preeminent publisher of exceptional world literature.

While sharing accomplishments is important, we also want to increase transparency and continue to maintain open lines of communication as we push to raise UConn’s research profile. In addition to sharing research and tech transfer metrics on the recently revamped UConn Research website, we encourage faculty and staff to reach out with suggestions regarding new opportunities and unmet needs. It is only together – as a team – that we will continue to drive the growth of scholarship, research, and creative pursuits at UConn.

I’d like to conclude with a personal note of gratitude. I cannot thank all of you enough for giving me the opportunity to work with so many talented, hardworking, and committed colleagues. To my staff, I am deeply honored to serve as VPR and grateful for your support, continued improvement, and service to our faculty and students. At the end of a hard day, I find great inspiration in the knowledge that UConn’s faculty and staff – whether they be musicians, chemists, or scholars of law or other disciplines – are some of the world’s most innovative and active researchers. Thank you for making UConn a special place with a vibrant community of caring, collaborative people.

We are opening a new chapter for UConn with a new President who is focused on our excellence, strengths, and new opportunities. I look forward to this journey with all of you, and please remember my door is always open!

Cheers,

Dr. Radenka Maric

Vice President for Research, UConn/UConn Health

Scholarship Facilitation Fund Announcement

Dear Colleagues,

I’m very pleased to announce that the Office of the Vice President for Research (OVPR) has recently finalized award decisions for the Scholarship Facilitation Fund (SFF) Program. Through this program, the OVPR is able to provide up to $2,000 to UConn faculty across all disciplines, on a competitive basis, to promote, support, and enhance research, scholarship, and creative endeavors. The 2019 competition marked the first time that in-residence faculty were eligible to apply for SFF funding, a factor that contributed to a high level of participation in this cycle.

Please join me in congratulating the 2019 SFF recipients who competed in a highly selective competition.

For more information about the competition, visit the program website.

Thank you for helping to foster the culture of excellence in your schools/colleges, departments, and centers that allows UConn faculty to engage in research, scholarship, and creative activities at the highest levels.

Cheers,
Dr. Radenka Maric
Vice President for Research
UConn/UConn Health

Prospective Basic Science Studies Involving Human Participants

On July 24th, NIH published a Guide Notice (NOT-OD-19-126) announcing the extension of delayed enforcement of registering and results reporting of Basic Experimental Studies involving Humans (BESH trials) on ClinicalTrials.gov through September 24, 2021. BESH trials are basic research projects exploring fundamental aspects of phenomena that involve human participants.

In a previous RFI (NOT-OD-18-217), NIH solicited feedback from the scientific community about challenges in reporting BESH trials on the ClinicalTrials.gov platform and several primary challenges were identified. Therefore, NIH has determined that more time is needed to address these challenges. In the interim, to meet NIH’s registration and results reporting requirement, alternative publicly available platforms should be used as described at the time of application in the Dissemination Plan attachment.

Please note this extension does not change the requirement for clinical trials to be registered on ClinicalTrials.gov.

 

For questions about this notice or your ClinicalTrials.gov requirement, please contact Ellen Ciesielski, 860.679.6004.

 

 

InfoEd for Storrs/Regional Campuses Unavailable July 27, 2019 10:00 PM – July 30, 2019 8:00 AM

The Office of the Vice President for Research (OVPR), Research IT Services would like to notify researchers and administrators that the InfoEd eRA portal serving sponsored program proposals, IRB and IACUC protocols, and conflict of interest (COI) disclosures for the Storrs and regional campuses will be offline for a system upgrade between 10:00 PM, Saturday July 27, 2019 and 8:00 AM, Tuesday July 30, 2019. This upgrade includes numerous improvements to modernize the user interface and address bugs in previous versions of the software. It also positions the University to roll out new features of the software in upcoming months. InfoEd for UConn Health will be unaffected by the change.

During the planned outage period, access to the InfoEd portal will be unavailable.  Researchers and department administrators will not be able to view or submit proposals, protocols, or financial conflict of interest disclosures through the InfoEd system. However, this outage is not anticipated to affect the submission of proposals to external sponsors, as they are not currently submitted through InfoEd. Please be aware that OVPR staff will not be able to process these records electronically during the maintenance window.

Other systems that rely on the InfoEd Storrs/regional campus eRA portal (e.g. Effort Reporting & Commitments [ERC], Current & Pending Support, AR Billing, SPS dashboards, and OVPR Reporting) will not be updated once the maintenance window begins.  Depending on the system, these other applications may or may not be accessible during the upgrade especially if they link directly into the InfoEd system records. We continue to evaluate these systems that interface with InfoEd and will update their status as the upgrade date approaches.

Once service is restored, users will be able to login and interact normally with all the affected systems.

We appreciate your understanding and cooperation as we conduct this necessary upgrade and improve upon the systems. Should you have any technical questions, please contact the eRA Help Desk at era-support@uconn.edu or 860.486.7944. If you need to report serious unanticipated adverse events or human subjects protocol deviations while the system is down, please call the IRB office at 860.486.0986.  If you have an urgent COI submission during the maintenance period, please call 860.679.3276. Please continue to reach out to SPS staff as you would normally.

Important Information from the NIH and NSF

Dear Investigator,

On July 10th, the National Institutes of Health (NIH) published a reminder on NIH Policies on Other Support and on Policies related to Financial Conflicts of Interest and Foreign Components.  This was followed on July 11th by a Dear Colleague Letter on protecting research funded by the National Science Foundation (NSF) from NSF Director, Dr. France Córdova. These notices relate to the ongoing concerns regarding foreign influence in federally funded research.

In response to these publications, the OVPR recommends that any collaborations with foreign entities or individuals, or appointments with foreign entities (including foreign talent or similar programs) be disclosed to the NIH or NSF program officer, your Dean, and the OVPR (contacts and additional information listed below).

The OVPR has posted additional guidance on our site regarding Active and Pending Support and Foreign Collaborations. For any questions or for guidance on this and other related matters, please contact:

Thank you for your cooperation,

Radenka Maric, PhD
Vice President for Research
UConn/UConn Health

 

 

Important Information from the NIH and NSF for UConn/UConn Health Investigators

The NSF Letter references the draft NSF Proposal and Award Policies & Procedures Guide published in May 2019.  Clarifications in the draft Guide related to current and pending support and biographical sketches include:

  • Providing information for all current and pending support irrespective of whether such support is provided through the proposing organization or directly to the individual.
  • Expanding examples of current and pending support to include non-profit organizations and consulting agreements.
  • Reporting all projects and activities requiring a time commitment (no minimum has been established), even if the support received is only in-kind.
  • Appointments should include any titled academic, professional, or institutional position whether or not remuneration is received.

The Dear Colleague Letter also states the NSF will be issuing a policy that NSF personnel and Intergovernmental Personnel Act (IPA) assigned personnel cannot participate in foreign government talent-recruitment programs.

The NIH Notice reminds applicants that in regards to Other Support, they must:

  • List all positions and scientific appointments, both domestic and foreign, held by senior/key personnel which are relevant to an application including affiliations with foreign entities or governments such as titled academic, professional, or institutional appointments whether or not remuneration is received, and whether full-time, part-time, or voluntary (including adjunct, visiting, or honorary).
  • Report all resources and other support for all individuals designated in an application as senior/key personnel – including the program director/principal investigator and other individuals who contribute to the scientific development or execution of a project in a substantive, measurable way, whether or not they request salaries or compensation. All current support for ongoing projects must be included, irrespective of whether such support is provided through the applicant organization, through another domestic or foreign organization, or is provided directly to an individual who supports the senior/key personnel’s research efforts.
  • Report all current projects and activities involving senior/key personnel, even if the support received is only in-kind (e.g. office/laboratory space, equipment, supplies, employees), including, but not limited to, foreign financial support, research or laboratory personnel, lab space, scientific materials, selection to a foreign “talents” or similar-type program, or other foreign or domestic support.
  • Provide the total award amount for the entire award period covered (including facilities and administrative costs), as well as the number of person-months (or partial person-months) per year to be devoted to the project by the senior/key personnel.

 

The Notice also reminds applicants of the need to determine whether projects include a foreign component, defined as the existence of any “significant scientific element or segment of a project” outside of the United States including:

  • Performance of work by a researcher or recipient in a foreign location, whether or not NIH grant funds are expended and/or
  • Performance of work by a researcher in a foreign location employed or paid for by a foreign organization, whether or not NIH grant funds are expended.

 

If a significant portion of a project will be conducted outside the United States, then there is a foreign component and NIH prior approval is required.  If all project activity is conducted within the United States, but there is a non-U.S. resource supporting the project, it must be reported as other support.

Program in Accelerated Therapeutics for Healthcare (PATH) Awards

Dear Colleagues,

I’m very pleased to announce that the Office of the Vice President for Research (OVPR) has recently finalized award decisions for the inaugural cycle of the Program in Accelerated Therapeutics for Healthcare (PATH).  PATH is a partnership that includes the OVPR, the School of Pharmacy, and the School of Medicine to accelerate the translational pathway for researchers to convert their discoveries to new medical therapeutics. Under PATH, funding is provided to academic research programs designed to quickly develop novel therapeutic approaches focusing on well validated molecular targets for a specific disease area with an unmet treatment need in the current commercial marketplace. Projects focusing on a wide range of therapeutic interventions (small molecule, biologic, antibody, peptide, gene therapy) are eligible for consideration.

Given your leadership role in the University, I want you to be among the first to hear the results of this competition so you can join me in congratulating the awardees.  Seven PATH grants were awarded in two categories after a highly selective competition:

 

PATH Trailblazer Grants – $75,000

Xiuling Lu, Pharmaceutical Science
Cutting Cancer at Its Root: Inhibition of Acute Leukemic Stem Cells Using Doxorubicin-Loaded Nanoparticles

Jessica Rouge, Chemistry
Determining the Pharmacology of a Novel DNAzyme-therapeutic Formulation for the Treatment of Allergic Airway Disease

 

PATH Ascent Grants – $10,000

Brian Aneskievich, Pharmaceutical Science
Establishing Protein Conformational Flexibility to Enhance Next-Step Drug-Screen Targeting

Nicholas Leadbeater, Chemistry
Towards Development of Novel Therapeutics for Treatment of Toxoplasmosis

Rajkumar Verma, Neuroscience, UConn Health
Discovery of Novel Purinergic P2X4 Receptor Antagonist for the Treatment of Ischemic Stroke

Simon White, Molecular and Cell Biology
Screening for Small Molecule Inhibitors against Enterovirus D68 2C Helicase

Ming Xu, Genetics and Genome Sciences, UConn Health
Discover Drugs Targeting Cellular Senescence to Improve Healthspan and Lifespan

For more information about PATH, visit the program website.

Thank you for helping to foster the culture of excellence in your schools/colleges, departments, and centers, that allows UConn faculty to engage in research, scholarship, and creative activities at the highest levels.

Cheers,

Radenka

OVPR Quarterly Reports – FY19Q2

Dear Colleagues,

Now that data have been finalized, I would like to provide you with several reports relating to sponsored program activity—both research and education/service—managed by Sponsored Program Services within the Office of the Vice President for Research at UConn and UConn Health. Please visit the OVPR website to view the following reports: https://ovpr.uconn.edu/news/quarterly-reports/

  • List of Proposals Submitted: FY19 2nd Quarter
  • List of Awards Received: FY19 2nd Quarter
  • Proposals, Awards, Expenditures: FY14-FY19Q2

In the reports, data are presented in two ways: by the PI’s Academic Home Department and by the Managing Department or Center/Institute. Please refer to the first pages of the reports for definitions and information regarding the data. Should you have any questions regarding these quarterly reports, please do not hesitate to contact me.

Please note that we have included an additional Summary of Sponsored Program Activity, which includes the Effective F&A rate on awards. This information provides a snapshot of our activity as compared to the same period last year.

The OVPR continues to seek creative solutions that allow UConn and UConn Health to grow our research enterprise through federal funding, industry partnerships, and collaboration with foundations. I am confident we can continue upward trends by continuing to work together, aggressively applying for extramural funding, and pursuing new channels of support for the tremendous research, scholarship, and creative activities taking place every day at UConn and UConn Health.

Thank you for your continued commitment and contribution to our students, to your research and scholarship, and to UConn/UConn Health.

Sincerely,
Radenka

 

Dr. Radenka Maric
Vice President for Research
UConn/UCH

2019 CARIC Award Recipients Announced

Dear Colleagues,

I am pleased to announce that two teams have been selected for funding in the inaugural cycle of CARIC (Convergence Awards for Research in Interdisciplinary Centers).

CARIC supports the development of collaborative, interdisciplinary teams bidding for major federally funded research initiatives. These initiatives can include large, multi-million-dollar research grants or even entire research centers.

2019 CARIC Awards:

  • David Rowe, Director of the Center for Regenerative Medicine and Skeletal Development
    Bed to Bench (BTB) Collaboration for Skeletal Research
  • Yu Lei, Castleman Distinguished Professor, Chemical and Biomolecular Engineering
    Exposure, Health Effects, Sensing and Remediation of Emerging Contaminants Superfund Research Program (SRP) Center

The CARIC program will provide these projects with funding of up to $150,000 to support planning, outreach to strategic partners and proof-of-concept research for a year, with the possibility for renewal. This initial funding allows researchers to develop more competitive bids for prestigious national awards.

To learn more about CARIC, visit the website of the Office of the Vice President for Research.

Sincerely,

Dr. Radenka Maric
Vice President for Research
UConn/UConn Health

OVPR Quarterly Reports – FY19Q1

Dear Colleagues,

Now that data have been finalized, I would like to provide you with several reports relating to sponsored program activity—both research and education/service—managed by Sponsored Program Services within the Office of the Vice President for Research at UConn and UConn Health. Please visit the OVPR website to view the following reports:

  • List of Proposals Submitted: FY19 1st Quarter
  • List of Awards Received: FY19 1st Quarter
  • Proposals, Awards, Expenditures: FY14-FY19Q1

In the reports, data are presented in two ways: by the PI’s Academic Home Department and by the Managing Department or Center/Institute. Please refer to the first pages of the reports for definitions and information regarding the data. Should you have any questions regarding these quarterly reports, please do not hesitate to contact me.

Please note that we have included an additional Summary of Sponsored Program Activity, which includes the Effective F&A rate on awards. This information provides a snapshot of our activity as compared to the same period last year.

The OVPR continues to seek creative solutions that allow UConn and UConn Health to grow our research enterprise through federal funding, industry partnerships, and collaboration with foundations. I am confident we can continue upward trends by continuing to work together, aggressively applying for extramural funding, and pursuing new channels of support for the tremendous research, scholarship, and creative activities taking place every day at UConn and UConn Health.

Thank you for your continued commitment and contribution to our students, to your research and scholarship, and to UConn/UConn Health.

Sincerely,
Radenka